文献速递冠心病外科瓣膜外科主动脉外科

红细胞储存时间对心脏手术后主要并发症影响的随机试验

Effect of red blood cell storage duration on major postoperative complications in cardiac surgery: A randomized trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-10-16

该随机试验纳入1387例接受冠状动脉旁路移植、瓣膜或升主动脉手术且术中及术后住院期间输血的患者,比较输注≤14天(中位11天)与≥20天(中位25天)红细胞对复合发病率和死亡率的影响;结果显示复合终点OR 0.77(95%CI 0.50-1.19;

要点

  • 心脏手术输血患者中,年轻红细胞(≤14天)与老年红细胞(≥20天)的复合发病率和死亡率无显著差异。
  • 年轻红细胞组院内死亡率2.1% vs 老年组3.4%,但所有置信区间均跨1.0。
  • 试验因入组困难提前终止,且未评估储存35-42天红细胞的效果。

核心结论

  • 该试验既不能支持也不能否定输注较年轻或较老年红细胞单位的疗效。
  • 储存时间更长的红细胞(35-42天)效果仍未验证。

研究设计与样本

  • 随机试验,2007年7月至2016年5月纳入3835例成人心脏手术患者,随机接受≤14天或≥20天红细胞输注。
  • 2448例未输血患者被排除,最终改良意向治疗分析纳入1387例(年轻组701例,老年组686例)。
  • 主要终点为复合发病率和死亡率,采用广义估计方程(GEE)模型分析;试验因入组限制提前终止。

主要发现

  • 共输注5470单位红细胞,年轻组2783单位,老年组2687单位。
  • 年轻红细胞组院内死亡率2.1%(n=15)低于老年组3.4%(n=23),其他不良事件(除房颤外)发生率也较低,但所有置信区间均跨1.0。

临床怎么用

  • 当前证据不足以支持为减少心脏手术后并发症而常规选择特定储存时间的红细胞。
  • 临床输血决策仍需综合考虑患者个体情况和血库供应。

局限性

  • 试验因入组困难提前终止,样本量可能不足。
  • 未评估储存35-42天红细胞的效果。
  • 改良意向治疗分析排除了大量未输血患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although observational studies suggest an association between transfusion of older red blood cell (RBC) units and increased postoperative risk, randomized trials have not supported this. The objective of this randomized trial was to test the effect of RBC storage age on outcomes after cardiac surgery. METHODS: From July 2007 to May 2016, 3835 adults undergoing coronary artery bypass grafting, cardiac valve procedures, or ascending aorta repair, either alone or in combination, were randomized to transfusion of RBCs stored for ≤14 days (younger units) or for ≥20 days (older units) intraoperatively and throughout the postoperative hospitalization. According to protocol, 2448 patients were excluded because they did not receive RBC transfusions. Among the remaining 1387 modified intent-to-treat patients, 701 were randomized to receive younger RBC units (median age, 11 days) and the remaining 686 to receive older units (median age, 25 days). The primary endpoint was composite morbidity and mortality, analyzed using a generalized estimating equation (GEE) model. The trial was discontinued midway owing to enrollment constraints. RESULTS: A total of 5470 RBC units were transfused, including 2783 in the younger RBC storage group and 2687 in the older RBC storage group. The GEE average relative-effect odds ratio was 0.77 (95% confidence interval [CI], 0.50-1.19; P = .083) for the composite morbidity and mortality endpoint. In-hospital mortality was lower for the younger RBC storage group (2.1% [n = 15] vs 3.4% [n = 23]), as was occurrence of other adverse events except for atrial fibrillation, although all CIs crossed 1.0. CONCLUSIONS: This clinical trial, which was stopped at its midpoint owing to enrollment constraints, supports neither the efficacy nor the futility of transfusing either younger or older RBC units. The effects of transfusing RBCs after even more prolonged storage (35-42 days) remains untested.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Koch CG, Sessler DI, Duncan AE, et al. Effect of red blood cell storage duration on major postoperative complications in cardiac surgery: A randomized trial. J Thorac Cardiovasc Surg. 2019. PMID: 31813538. doi:10.1016/j.jtcvs.2019.09.165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。